Delaware, March 07, 2017 (GLOBE NEWSWIRE) -- The report “World Congestive Heart Failure (CHF) Treatment Devices Market - Opportunities and Forecasts, 2015 - 2022”, available on MarketIntelReports, estimates that the market will exhibit a CAGR of 5.5% till 2022.
Browse Market Data Tables and List Figures spread through 135 Pages and an in-depth TOC on "Congestive Heart Failure (CHF) Treatment Devices Market" http://www.marketintelreports.com/report/allied0014/world-congestive-heart-failure-chf-treatment-devices-market--opportunities-and-forecasts-2015--2022
Scope & Regional Forecast of the Congestive Heart Failure Treatment Devices Market
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
The world CHF treatment devices market was evaluated at $10,127.2 million in 2015, and is estimated to reach $14,823.3 million by 2022, with a CAGR of 5.5% over the forecast period. This is primarily attributed to the constantly changing lifestyle habits (such as unhealthy dietary habits, excessive alcohol consumption, smoking, obesity, and lack of physical activity) which make individuals more susceptible to arrhythmia and heart failure. In addition, a number of factors such as the large number of technological advancements in CHF treatment devices, increased adoption rate of these devices, and rising emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market. Conversely, stringent government regulations for the approval of CHF treatment devices, high cost of, and high preference to drugs for CHF treatment are some of the factors restraining the market growth.
Get Sample PDF Brochure @ http://www.marketintelreports.com/pdfdownload.php?id=allied0014
Key Benefits
- The study provides an in-depth analysis of the world CHF treatment devices market with current trends and future estimations to elucidate the imminent investment pockets in the market.
- The report provides a quantitative analysis from 2015 to 2022 that would enable the stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of the world CHF treatment devices market, by product, helps in understanding the various types of devices used for the treatment of CHF and other related cardiac conditions.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
- SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.
Segmentations & Key Players Involved in the Congestive Heart Failure Treatment Devices Market
The Congestive Heart Failure Treatment Devices Market can be broken down into various segmentations on the basis of -
Pacemaker: Implantable Pacemakers and External Pacemakers.
Cardiac Resynchronization Therapy (CRT): Cardiac Resynchronization Therapy-Pacemakers (CRT-P) and Cardiac Resynchronization Therapy-Defibrillators (CRT-D).
Implantable Cardioverter Defibrillators (ICDs): Transvenous Implantable Cardioverter Defibrillator (T-ICDs) and Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs).
Ventricular Assist Devices (VADs): Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD) and Biventricular Assist Device (BIVAD).
Geographical Location: North America, Europe, Asia-Pacific and LAMEA.
Some of the key players involved in the Congestive Heart Failure Treatment Devices Market are as follows:
- Boston Scientific Corporation
- HeartWare International Inc.
- Jarvik Heart, Inc.
- LivaNova PLC
- ReliantHeart, Inc.
- St. Jude Medical, Inc.
- Biotronik SE & Co. KG
Why buy this report?
- Get a detailed picture of the Congestive Heart Failure Treatment Devices Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase copy of research report @ http://www.marketintelreports.com/purchase.php?id=allied0014
About Us:
MarketIntelReports (MIR) aims to empower our clients to successfully manage and outperform in their business decisions. We do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
MarketIntelReports currently has more than 150,000 plus titles and 100+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Media Contact
Company Name: Market Intel Reports
Contact Person: Mayur S
Email: sales@marketintelreports.com
Phone: 1-302-261-5343
Address: 2712 Centerville Road, Suite 400
City: Wilmington
State: Delaware
Country: United States